BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synthon Pharmaceuticals, Ltd. 

6330 Quadrangle Drive, Suite 305

Chapel Hill  North Carolina  27514  U.S.A.
Phone: 919-493-6006 Fax: 919-493-6104


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Synthon Pharmaceuticals’s Anti-HER2 ADC Frontrunner SYD985 Outperforms Only Available HER2-targeting ADC 4/2/2014 9:31:05 AM    More...
Synthon Pharmaceuticals Announces Successful Outcome Of The Phase 3 GATE Study With Its Generic Glatiramer Acetate 3/27/2014 9:25:12 AM    More...
Synthon Pharmaceuticals Enters Into Global License Agreement With Amgen (AMGN) and Watson Pharmaceuticals, Inc. (WPI) for Biosimilar Trastuzumab 7/18/2012 9:18:09 AM    More...
Synthon Pharmaceuticals Appoints Paul Roos as Chief Financial Officer 5/7/2012 10:20:40 AM    More...
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab 3/22/2012 1:30:10 PM    More...
Perrigo Company (PRGO) and its Partner Synthon Pharmaceuticals Launch Levocetirizine Solution - Generic Equivalent to Xyzal(R) Oral Solution 11/8/2011 6:02:57 AM    More...
Perrigo Co. (PRGO)'s Partner Synthon Pharmaceuticals Receives FDA Tentative Approval for Levocetirizine Solution - Generic Equivalent to Xyzal(R) Oral Solution 5/18/2011 9:01:45 AM    More...
Breckenridge Pharmaceutical, Inc. and Synthon Pharmaceuticals Announces Settlement of Actos(R) (Pioglitazone Hydrochloride) Patent Litigation With Takeda Pharmaceutical Co. Ltd. (TKDG.DE) 5/16/2011 9:58:13 AM    More...
Perrigo Company (PRGO) Confirms That its Partner Synthon Pharmaceuticals Has Filed for Generic Version of Xyzal(R) 6/24/2009 10:34:29 AM    More...
Perrigo Company (PRGO) Acquires Exclusive Sales and Distribution Rights to Allergy Drug Levocetirizine from Synthon Pharmaceuticals 9/8/2008 6:49:58 AM    More...
12